As more and more novel medical products are brought to the market, how they perform in day-to-day clinical practice has become an important question. Clinicians, patients, family members, regulators, and payers are all eager to gain more insight into the utility of therapeutic and preventive regimens through Real World Evidence.
The Health Data Research Center (HDRC) at National Taiwan University is uniquely positioned in Taiwan to access and evaluate Real World Evidence of major medical products in Taiwan. Using the population-based National Health Insurance (NHI) data, which is linkable to cancer registry and mortality data, investigators and experienced analysts could adopt sophisticated observational research methods to address pertinent clinical and public health questions related to effectiveness, safety, and cost-effectiveness of medical products. As an integral member of the NTU community, the HDRC will strive to work with scientific investigators within NTU as well as global partners to provide high quality data and evidence about medical products in Taiwan.
Oct. 23, 2012 HDRC was established through a core grant from the government.